title: Expression of mPGES-1 and IP mRNA is reduced by LLLT in both subplantar and brain tissues in the model of peripheral inflammation induced by carrageenan.
abstract: The increase in PGE2 production by microsomal PGE synthase-1 (mPGES-1) in CNS contributes to the severity of the inflammatory and pain responses in the model of edema formation and hyperalgesia induced by carrageenan. PGI2, alike to PGE2, plays an important role in the inflammation. Low-level laser therapy (LLLT) has been used in the treatment of inflammatory pathologies, reducing both pain and the acute inflammatory process. In this work, we studied the effect of LLLT on the expression of both mPGES-1 and IP messenger RNA (mRNA), in either subplantar or total brain tissues obtained from rats submitted to model of edema formation and hyperalgesia induced by carrageenan administration. The test sample consisted of 30 rats divided into five groups: A1 (control-saline), A2 (carrageenan-0.5 mg/paw), A3 (carrageenan-0.5 mg/paw + LLLT), A4 (carrageenan-1.0 mg/paw), and A5 (carrageenan-1.0 mg/paw + LLLT). The animals from groups A3 and A5 were irradiated 1 h after induction of inflammation by carrageenan injection. Continuous-wave red laser with wavelengths of 660 nm and dose of 7.5 J/cm(2) was used. Six hours after carrageenan-induced inflammation, mPGES-1 and prostacyclin receptor (IP) mRNA expression were significantly increased both in subplantar and brain tissues. LLLT was able to reduce both mPGES-1 and IP mRNA expression in subplantar and brain tissues. We suggest that LLLT is able to reduce both inflammation and hyperalgesia observed in the model of edema formation and hyperalgesia induced by carrageenan, by a mechanism involving the decrease in the expression of both mPGES-1 and IP.
authors: Instituto de Pesquisa e Desenvolvimento - IP&D, Universidade do Vale do Paraíba - UNIVAP, Av. Shishima Hifumi, 2911. Urbanova, CEP 12244-000, São José dos Campos, SP, Brazil.
authors: Luciene Reginato
authors: LR
authors: Chagas
authors: José Antonio
authors: JA
authors: Silva
authors: Juliana
authors: J
authors: de Almeida Pires
authors: Maricilia S
authors: MS
authors: Costa
mesh_terms: D000818:Animals; D001921:Brain / Q000276:immunology / Q000378:metabolism* / Q000528:radiation effects; D002351:Carrageenan; D015536:Down-Regulation; D004487:Edema / Q000139:chemically induced / Q000378:metabolism / Q000532:radiotherapy*; D005528:Foot / Q000473:pathology / Q000528:radiation effects; D015870:Gene Expression / Q000528:radiation effects; D006614:Hindlimb / Q000378:metabolism* / Q000473:pathology / Q000528:radiation effects; D006930:Hyperalgesia / Q000378:metabolism / Q000532:radiotherapy; D019746:Intramolecular Oxidoreductases / Q000235:genetics* / Q000378:metabolism; D054023:Lasers, Semiconductor / Q000627:therapeutic use*; D028022:Low-Level Light Therapy; D008297:Male; D000071876:Prostaglandin-E Synthases; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D011982:Receptors, Prostaglandin / Q000235:genetics / Q000378:metabolism*
chemical_list: D012333:RNA, Messenger; D011982:Receptors, Prostaglandin; D002351:Carrageenan; D019746:Intramolecular Oxidoreductases; D000071876:Prostaglandin-E Synthases